Literature DB >> 34989821

[Citrus paradisi (grapefruit)-a negative interaction with a statin].

Katja Sigrist1, Johanna Winkler2, Andrea Westphalen3, Bernd Yuen3.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2022        PMID: 34989821     DOI: 10.1007/s00063-021-00893-2

Source DB:  PubMed          Journal:  Med Klin Intensivmed Notfmed        ISSN: 2193-6218            Impact factor:   0.840


× No keyword cloud information.
  5 in total

Review 1.  Statin Safety and Associated Adverse Events: A Scientific Statement From the American Heart Association.

Authors:  Connie B Newman; David Preiss; Jonathan A Tobert; Terry A Jacobson; Robert L Page; Larry B Goldstein; Clifford Chin; Lisa R Tannock; Michael Miller; Geetha Raghuveer; P Barton Duell; Eliot A Brinton; Amy Pollak; Lynne T Braun; Francine K Welty
Journal:  Arterioscler Thromb Vasc Biol       Date:  2019-02       Impact factor: 8.311

Review 2.  Interactions between grapefruit juice and cardiovascular drugs.

Authors:  David G Bailey; George K Dresser
Journal:  Am J Cardiovasc Drugs       Date:  2004       Impact factor: 3.571

Review 3.  Bench-to-bedside review: Rhabdomyolysis -- an overview for clinicians.

Authors:  Ana L Huerta-Alardín; Joseph Varon; Paul E Marik
Journal:  Crit Care       Date:  2004-10-20       Impact factor: 9.097

4.  Blood purification with a cytokine adsorber for the elimination of myoglobin in critically ill patients with severe rhabdomyolysis.

Authors:  Christina Scharf; Uwe Liebchen; Michael Paal; Michael Irlbeck; Michael Zoller; Ines Schroeder
Journal:  Crit Care       Date:  2021-01-28       Impact factor: 9.097

5.  Myoglobin clearance with continuous veno-venous hemodialysis using high cutoff dialyzer versus continuous veno-venous hemodiafiltration using high-flux dialyzer: a prospective randomized controlled trial.

Authors:  Lorenz Weidhase; Jonathan de Fallois; Elena Haußig; Thorsten Kaiser; Meinhard Mende; Sirak Petros
Journal:  Crit Care       Date:  2020-11-11       Impact factor: 9.097

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.